小鼠卵巢组织的超速冻存法研究

目的　本实验通过对小鼠卵巢组织进行冻存研究 ,掌握卵巢的低温生物学特性 ,摸索出一种简便有效的组织器官冻存法 ,为卵巢移植及器官冷冻提供有用的技术方法。方法　通过对小鼠卵巢组织进行慢速程序法与快速液氮蒸汽法冻存 ,比较分析了不同方法所需保护剂种类、浓度、渗透平衡时间。采用对解冻后卵巢组织超微结构观察、组织化学染色、激素测定及自体、异体移植后动情期的恢复作为评价指标。结果与结论　通过上述实验表明用同种冷冻保护剂 ,液氮蒸汽法冻存的卵巢组织超微结构保存良好 ;组织化学染色示其活性与程序法冻存组织相同 ;自体、异体移植后 ,小鼠动情周期的恢复率及血清雌二醇水平各项指标均与慢速程序法冷冻无显著性差异     

小鼠睾丸组织慢速冷冻保存工艺的优化研究

目的 冷冻保存睾丸组织用于后期移植,是除精子冻存以外保持男性生育力的另一有效途径。本文对块状睾丸组织常用的慢速冷冻降温程序进行了改进。方法 通过缩短保护剂加载时间、提高第一阶段的冷却速率、第二阶段直接投入液氮等方法对小鼠睾丸组织进行冷冻保存。在不同温度对小鼠睾丸组织冻存体系进行诱导冰晶成核并冻存,降低睾丸组织慢速冷冻保存所需保护剂浓度。结果 改进的两步法冻后组织内生殖细胞的凋亡阴性率均较高,其中精原细胞98.4%、精母细胞99.2%、精子细胞88.4%、支持细胞98.1%,显著高于常用慢速冷冻组,与对照组均无显著性差异。相比于未置核组, -10℃置核可显著提高5% DMSO保护剂慢速冷冻保存的冻后效果,生殖细胞的凋亡阴性率为精原细胞82.9%、精子细胞92.1%、精母细胞93.2%及支持细胞88.9%,与较高浓度保护剂10% DMSO组冻存结果无显著性差异,说明置核能够降低所需保护剂的浓度,降低毒性损伤。结论 本研究通过改进两步法和置核提高了小鼠睾丸组织冻后的质量,为临床上人睾丸组织的冻存提供参考。     

深低温冷冻技术的研究进展

细胞及组织的深低温保存有较高的临床应用和研究价值,在冷冻保存技术中两个关键领域首先发展的是冷冻控制率。冷冻保护剂能增加溶液粘性,提高冷冻速率从而保护细胞及组织免受冷冻损伤。对最佳冷冻保护剂的研究为保存临床应用的组织工程产品提供了理论依据。而玻璃化冷冻近年来越来越受到人们的关注,玻璃化冷冻技术具有冷冻速度快、冻融损伤小,操作简单等优点,能够提高复苏后的存活率。本文对深低温保护剂的组成、分类、应用及冷冻保存的重大进展和障碍进行了综述。     

黄鳝精液-80℃超低温冷冻保存试验

采用-80℃超低温冷冻方法对黄鳝精液冷冻保存技术进行了研究.获得如下结果:黄鳝精子在冻存前不需低温平衡过程;10%DMSO作为抗冻保护剂效果最好,以200 μL离心管为冻存容器,保存168 h,精子相对活力可达79%;以细管为冻存容器,精子相对活力可达88%.此结果为黄鳝精子冷冻保存库的建立提供了实验依据.     

BALB/C小鼠杂交瘤细胞冻存初探

自从Polge(1949)用甘油作为保护剂成功的冻存了Hela和L细胞以来,细胞冻存技术已日趋完善。本文对细胞株的冻存分别采用-70℃冰箱和常用的液氮深低温的方法。定期复苏,测定抗体效价,最后作染色体比较,至今已一年多,其结果令人满意。现将结果简要报告如下。方法1.细胞冻存:选择生长旺盛期,形态良好的细胞,按每ml细胞冻存液内含活细胞约1×106个,每支冻存管1ml。细胞冻存管置-20℃冰箱内15小时左右,分别放入液氮和-70℃冰箱内。经不同时期后取出作复苏及抗体效价比较。2.细胞复苏:取出冻存管,迅速浸入37℃水浴中,在1分钟内解冻后转种到已预制…     

衣藻细胞玻璃化超低温保存技术的研究

本研究以衣藻为材料,探讨其玻璃化超低温保存的条件和方法,结果表明,衣藻经含0.25mol/L蔗糖溶液的TAP培养基预培养一天后,在玻璃化冷冻保护剂中脱水5分钟,直接投稿液氮,48小时后快速化冻,去保护剂并用含0.5mol/L蔗糖溶液的TAP培养基境培养一天,再转到ATP培养基暗培养一天,最后置光照条件下恢复培养,其存活率可达31.45％,恢复培养后衣藻细胞的生长规律与未冻存的衣藻相一致。     

微流控法制备载卵母细胞水凝胶微球及其玻璃化保存

目的 通过微流控法制备载卵母细胞海藻酸钠微球,在低浓度保护剂下实现卵母细胞玻璃化保存。方法 采用流动聚焦型微流控芯片,通过调整芯片结构、海藻酸钠溶液浓度和流速比,制备大小均匀、空包率低、低温耐受的载卵母细胞海藻酸钠水凝胶微球。在低浓度低温保护剂下将微球玻璃化保存,复温后检测存活率,采用细胞松弛素B和氯化锶孤雌激活卵母细胞,与Cryotop玻璃化法对比卵母细胞存活率和卵裂率、囊胚率。结果 制备的海藻酸钠微球在冷冻复温前后的体积稳定且结构完整,在将卵母细胞包封在海藻酸钠水凝胶中后,空包率低,存活率、卵裂率和囊胚率与新鲜组相比无显著差异。在低浓度低温保护剂10% DMSO+10%乙二醇（EG）+0.5 mol/L海藻糖中玻璃化冻存后卵母细胞的存活率达到92.48%,卵裂率70.80%,囊胚率20.42%,与高浓度保护剂15% DMSO+15% EG+0.5 mol/L海藻糖中Cryotop玻璃化法相比无显著性差异。结论 本文设计制作了三通道内部交联芯片并用于卵母细胞玻璃化保存的微流控系统,可生成大小均匀、空包率低、低温耐受的载卵母细胞海藻酸钠水凝胶微球,在低浓度保护剂下实现玻璃化保存,为卵母细胞玻璃化保存方法提供新思路。     

小鼠卵慢速和快速降温及玻璃化冻存的比较研究

本文用４种冷冻模式：慢速降温（ＳＬ）,超快速降温（Ｑ１）和防冻剂组成不同的玻璃化法（Ｒ－ＦＶＭ和ＭＶＭ）对昆明小鼠卵进行冷冻保存的比较研究,并用体外受精技术检测冷冻复苏卵的受精能力。ＳＬ和Ｒ－ＦＶＭ的存活率分别为５５．１±１．２和６５．９±７．９,显著高于Ｑ１（２４．２±７．３）和ＭＶＭ（４．５±２．４）其受精率分别为７２．８±１．８和７３．９±０．４显著高于Ｑ１（５８．６±１１．２）和ＭＶＭ（４１．５±８．５）,而与对照组（７７．５±３．９）相似。结果表明：１）慢速降温程序（ＳＬ）和同时含有渗透性和非渗透性防冻剂的玻璃化法（Ｆ—ＲＶＭ）较适宜昆明小鼠卵的冻存;２）同时考虑冻存过程中的冰晶损伤和渗透压损伤是获得较好冻存结果的关键。     

低温显微装置及其对细胞胞内冰晶形成现象的观察

了解细胞在不同条件下的结冰可能性有助于设计低温保存方案。应用低温显微系统．本对快速冷冻的脐带血干细胞的结冰现象进行了研究。在没有低温保护剂时,胞内出现冰晶温度范围为-4℃— -13℃,在有10％二甲亚砜做低温保护剂时,胞内出现冰晶温度范围为-27℃— -38℃。利用得到的实验数据,根据Toner提出的胞内冰晶形成模型,对有关参数进行了拟合。     

恒河猴(Macaca mulatta)肾细胞冻存复苏培养及其生物学特性的研究

本文使用深低温(-196℃)冻结保存动物细胞技术,对胰酶分散的恒河猴肾细胞的冻存,复苏培养及其生物学特性进行了研究。结果表明、液氮冻存2—58周的恒河猴肾细胞,其平均存活率为63.3—74.4％。复苏培养细胞于6—7天形成緻密单层,对脊髓灰质炎病毒敏感;国产二甲基亚砜可以用作冻存细胞的保护剂;复苏培养的细胞核型正常;其生物学特性与未冻的原代细胞一致。     

Improved vitrification solutions based on the predictability of vitrification solution toxicity

Long-term preservation of complex engineered tissues and organs at cryogenic temperatures in the absence of ice has been prevented to date by the difficulty of discovering combinations of cryoprotectants that are both sufficiently non-toxic and sufficiently stable to allow viability to be maintained and ice formation to be avoided during slow cooling to the glass transition temperature and subsequent slow rewarming. A new theory of the origin of non-specific cryoprotectant toxicity was shown to account, in a rabbit renal cortical slice model, for the toxicities of 20 vitrification solutions and to permit the design of new solutions that are dramatically less toxic than previously known solutions for diverse biological systems. Unfertilized mouse ova vitrified with one of the new solutions were successfully fertilized and regained 80% of the absolute control (untreated) rate of development to blastocysts, whereas ova vitrified in VSDP, the best previous solution, developed to blastocysts at a rate only 30% of that of controls. Whole rabbit kidneys perfused at -3 degrees C with another new solution at a concentration of cryoprotectant (8.4M) that was previously 100% lethal at this temperature exhibited no damage after transplantation and immediate contralateral nephrectomy. It appears that cryoprotectant solutions that are composed to be at the minimum concentrations needed for vitrification at moderate cooling rates are toxic in direct proportion to the average strength of water hydrogen bonding by the polar groups on the permeating cryoprotectants in the solution. Vitrification solutions that are based on minimal perturbation of intracellular water appear to be superior and provide new hope that the successful vitrification of natural organs as well as tissue engineered or clonally produced organ and tissue replacements can be achieved.     

Water crystallization within rat precision-cut liver slices in relation to their viability

This study examined whether tissue vitrification, promoted by partitioning within the tissue, could be the mechanism explaining the high viability of rat liver slices, rapidly frozen after preincubation with 18% Me2SO or VS4 (a 7.5 M mixture of Me2SO, 1,2-propanediol, and formamide with weight ratio 21.5:15:2.4). To achieve this, we first determined the extent to which crystallization or vitrification occurred in cryoprotectant solutions (Me2SO and VS4) and within liver slices impregnated with these solutions. Second, we determined how these events were related to survival of slices after thawing. Water crystallization was evaluated by differential scanning calorimetry and viability was determined by histomorphological examination of the slices after culturing at 37 degrees C for 4 h. VS4-preincubated liver slices indeed behaved differently from bulk VS4 solution, because, when vitrified, they had a lower tendency to devitrify. Vitrified VS4-preincubated slices that were warmed sufficiently rapid to prevent devitrification had a high viability. When VS4 was diluted (to 75%) or if warming was not fast enough to prevent ice formation, slices had a low viability. With 45% Me2SO, low viability of cryopreserved slices was caused by cryoprotectant toxicity. Surprisingly, liver slices preincubated with 18% Me2SO or 50% VS4 had a high viability despite the formation of ice within the slice. In conclusion, tissue vitrification provides a mechanism that explains the high viability of VS4-preincubated slices after ultrarapid freezing and thawing (>800 degrees C/min). Slices that are preincubated with moderately concentrated cryoprotectant solutions (18% Me2SO, 50% VS4) and cooled rapidly (100 degrees C/min) survive cryopreservation despite the formation of ice crystals within the slice.     

Physical and biological aspects of renal vitrification

Cryopreservation would potentially very much facilitate the inventory control and distribution of laboratory-produced organs and tissues. Although simple freezing methods are effective for many simple tissues, bioartificial organs and complex tissue constructs may be unacceptably altered by ice formation and dissolution. Vitrification, in which the liquids in a living system are converted into the glassy state at low temperatures, provides a potential alternative to freezing that can in principle avoid ice formation altogether. The present report provides a brief overview of the problem of renal vitrification. We report here the detailed case history of a rabbit kidney that survived vitrification and subsequent transplantation, a case that demonstrates both the fundamental feasibility of complex system vitrification and the obstacles that must still be overcome, of which the chief one in the case of the kidney is adequate distribution of cryoprotectant to the renal medulla. Medullary equilibration can be monitored by monitoring urine concentrations of cryoprotectant, and urine flow rate correlates with vitrification solution viscosity and the speed of equilibration. By taking these factors into account and by using higher perfusion pressures as per the case of the kidney that survived vitrification, it is becoming possible to design protocols for equilibrating kidneys that protect against both devitrification and excessive cryoprotectant toxicity.     

Physical and biological aspects of renal vitrification

Cryopreservation would potentially very much facilitate the inventory control and distribution of laboratory-produced organs and tissues. Although simple freezing methods are effective for many simple tissues, bioartificial organs and complex tissue constructs may be unacceptably altered by ice formation and dissolution. Vitrification, in which the liquids in a living system are converted into the glassy state at low temperatures, provides a potential alternative to freezing that can in principle avoid ice formation altogether. The present report provides a brief overview of the problem of renal vitrification. We report here the detailed case history of a rabbit kidney that survived vitrification and subsequent transplantation, a case that demonstrates both the fundamental feasibility of complex system vitrification and the obstacles that must still be overcome, of which the chief one in the case of the kidney is adequate distribution of cryoprotectant to the renal medulla. Medullary equilibration can be monitored by monitoring urine concentrations of cryoprotectant, and urine flow rate correlates with vitrification solution viscosity and the speed of equilibration. By taking these factors into account and by using higher perfusion pressures as per the case of the kidney that survived vitrification, it is becoming possible to design protocols for equilibrating kidneys that protect against both devitrification and excessive cryoprotectant toxicity.     

Cryopreservation of rat precision-cut liver and kidney slices by rapid freezing and vitrification

Precision-cut tissue slices of both hepatic and extra-hepatic origin are extensively used as an in vitro model to predict in vivo drug metabolism and toxicity. Cryopreservation would greatly facilitate their use. In the present study, we aimed to improve (1) rapid freezing and warming (200 degrees C/min) using 18% Me(2)SO as cryoprotectant and (2) vitrification with high molarity mixtures of cryoprotectants, VM3 and VS4, as methods to cryopreserve precision-cut rat liver and kidney slices. Viability after cryopreservation and subsequent 3-4h of incubation at 37 degrees C was determined by measuring ATP content and by microscopical evaluation of histological integrity. Confirming earlier studies, viability of rat liver slices was maintained at high levels by rapid freezing and thawing with 18% Me(2)SO. However, vitrification of liver slices with VS4 resulted in cryopreservation damage despite the fact that cryoprotectant toxicity was low, no ice was formed during cooling and devitrification was prevented. Viability of liver slices was not improved by using VM3 for vitrification. Kidney slices were found not to survive cryopreservation by rapid freezing. In contrast, viability of renal medullary slices was almost completely maintained after vitrification with VS4, however vitrification of renal cortex slices with VS4 was not successful, partly due to cryoprotectant toxicity. Both kidney cortex and medullary slices were vitrified successfully with VM3 (maintaining viability at 50-80% of fresh slice levels), using an optimised pre-incubation protocol and cooling and warming rates that prevented both visible ice-formation and cracking of the formed glass. In conclusion, vitrification is a promising approach to cryopreserve precision-cut (kidney) slices.     

Vitreous cryopreservation maintains the function of vascular grafts

Avoidance of ice formation during cooling can be achieved by vitrification, which is defined as solidification in an amorphous glassy state that obviates ice nucleation and growth. We show that a vitrification approach to storing vascular tissue results in markedly improved tissue function compared with a standard method involving freezing. The maximum contractions achieved in vitrified vessels were >80% of fresh matched controls with similar drug sensitivities, whereas frozen vessels exhibited maximal contractions below 30% of controls and concomitant decreases in drug sensitivity. In vivo studies of vitrified vessel segments in an autologous transplant model showed no adverse effects of vitreous cryopreservation compared with fresh tissue grafts.     

Vitrification assays with embryos from a cold tolerant sub-arctic fish species

Pseudopleuronectes americanus is a Northern teleost species that produces antifreeze proteins (AFPs) to protect them from freezing during the winter. These AFPs bind to ice crystals to inhibit their growth, and they also protect cell membranes at low temperatures. In this study, vitrification trials were done with fish embryos at three different developmental stages, using two different protocols for incorporating the vitrifying solutions. Toxicity of the cryoprotectants and permeability to dimethyl sulfoxide were analyzed. Embryos were vitrified in 0.5 ml straws by direct immersion in liquid nitrogen, and their morphology and development analyzed following thaw. The embryos responded well to vitrification as evidenced by the high percentage that exhibited good morphology following thaw. Although none of the embryos hatched, a small percentage (0.92%) of them showed active movements within the chorion and continued to develop for a number of days following thaw. This is the first record of post-thaw development of vitrified fish embryos.     

Effect of warming rate on the survival of vitrified mouse oocytes and on the recrystallization of intracellular ice

Successful cryopreservation demands there be little or no intracellular ice. One procedure is classical slow equilibrium freezing, and it has been successful in many cases. However, for some important cell types, including some mammalian oocytes, it has not. For the latter, there are increasing attempts to cryopreserve them by vitrification. However, even if intracellular ice formation (IIF) is prevented during cooling, it can still occur during the warming of a vitrified sample. Here, we examine two aspects of this occurrence in mouse oocytes. One took place in oocytes that were partly dehydrated by an initial hold for 12 min at -25 degrees C. They were then cooled rapidly to -70 degrees C and warmed slowly, or they were warmed rapidly to intermediate temperatures and held. These oocytes underwent no IIF during cooling but blackened from IIF during warming. The blackening rate increased about 5-fold for each five-degree rise in temperature. Upon thawing, they were dead. The second aspect involved oocytes that had been vitrified by cooling to -196 degrees C while suspended in a concentrated solution of cryoprotectants and warmed at rates ranging from 140 degrees C/min to 3300 degrees C/min. Survivals after warming at 140 degrees C/min and 250 degrees C/min were low (<30%). Survivals after warming at > or =2200 degrees C/min were high (80%). When warmed slowly, they were killed, apparently by the recrystallization of previously formed small internal ice crystals. The similarities and differences in the consequences of the two types of freezing are discussed.     

Vitrification of one-cell mouse embryos in cryotubes

Preventing intracellular ice formation is essential to cryopreserve cells. Prevention can be achieved by converting cell water into a non-crystalline glass, that is, to vitrify. The prevailing belief is that to achieve vitrification, cells must be suspended in a solution containing a high concentration of glass-inducing solutes and cooled rapidly. In this study, we vitrified 1-cell mouse embryos and examined the effect of the cooling rate, the warming rate, and the concentration of cryoprotectant on cell survival. Embryos were vitrified in cryotubes. The vitrification solutions used were EFS20, EFS30, and EFS40, which contained ethylene glycol (20, 30 and 40% v/v, respectively), Ficoll (24%, 21%, and 18% w/v, respectively) and sucrose (0.4 0.35, and 0.3 M, respectively). A 5-μl EFS solution suspended with 1-cell embryos was placed in a cryotube. After 2 min in an EFS solution at 23 °C, embryos were vitrified by direct immersion into liquid nitrogen. The sample was warmed at 34 °C/min, 4,600 °C/min and 6,600 °C/min. With EFS40, the survival was low regardless of the warming rate. With EFS30 and EFS20, survival was also low when the warming rate was low, but increased with higher warming rates, likely due to prevention of intracellular ice formation. When 1-cell embryos were vitrified with EFS20 and warmed rapidly, almost all of the embryos developed to blastocysts in vitro. Moreover, when vitrified 1-cell embryos were transferred to recipients at the 2-cell stage, 43% of them developed to term. In conclusion, we developed a vitrification method for 1-cell mouse embryos by rapid warming using cryotubes.     

Nonequilibrium cryopreservation of rabbit embryos using a modified (sealed) open pulled straw procedure

The study was designed to evaluate the efficiency of a modified (sealed) open pulled straw (mOPS) method for cryopreserving rabbit embryos by vitrification or rapid freezing. An additional objective was to determine whether the mOPS method could cause the vitrification of a cryoprotectant solution generally used in rapid freezing procedures. Two consecutive experiments of in vitro and in vivo viability were performed. In Experiment 1, the in vitro viability of rabbit embryos at the morula, compacted morula, early blastocyst and blastocyst stages was assessed after exposure to a mixture of 25% glycerol and 25% ethylene glycol (25GLY:25EG: vitrification solution) or 4.5 M (approximately 25% EG) ethylene glycol and 0.25 M sucrose (25EG:SUC: rapid freezing solution). Embryos were loaded into standard straws or mOPS and plunged directly into liquid nitrogen. The mOPS consisted of standard straws that were heat-pulled, leaving a wide opening for the cotton plug and a narrow one for loading embryos by capillarity. The embryos were aspirated into the mOPS in a column positioned between two columns of cryoprotectant solution separated by air bubbles. The mOPS were then sealed with polyvinyl-alcohol (PVA) sealing powder. The vitrification 25GLY:25EG solution became vitrified both in standard straws and mOPS, whereas the rapid freezing 25EG:SUC solution crystallized in standard straws, but vitrified in mOPS. The total number of embryos cryopreserved was 1695. Embryos cryopreserved after exposure to each solution in mOPS showed higher rates (88.2%) of survival immediately after thawing and removal of the cryoprotectant than those cryopreserved in 0.25 ml standard straws (78.8%; P < 0.0001). After culture, the developmental stage of the cryopreserved embryos significantly affected the rates of development to the expanded blastocyst stage. Regardless of the cryoprotectant used, lower rates of in vitro development were obtained when the embryos were cryopreserved at the morula stage, and higher rates achieved using embryos at blastocyst stages. Based on the results of Experiment 1, the second experiment was performed on blastocysts using the mOPS method. Experiment 2 was designed to evaluate the in vivo viability of cryopreserved rabbit blastocysts loaded into mOPS after exposure to 25GLY:25EG or 25EG:SUC. Embryos cryopreserved in mOPS and 25GLY:25EG solution gave rise to rates of live offspring (51.7%) not significantly different to those achieved using fresh embryos (58.5%). In conclusion, the modified (sealed) OPS method allows vitrification of the cryoprotectant solution at a lower concentration of cryoprotectants than that generally used in vitrification procedures. Rabbit blastocysts cryopreserved using a 25GLY:25EG solution in mOPS showed a similar rate of in vivo development after thawing to that shown by fresh embryos.